Activated MET acts as a salvage signal after treatment with alectinib, a selective ALK inhibitor, in ALK-positive non-small cell lung cancer

Publisher: Spandidos Publications

E-ISSN: 1791-2423|46|3|1025-1030

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.46, Iss.3, 2015-03, pp. : 1025-1030

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract